AG NPP709 is presently available on the market; nonetheless, no study has investigated the outcome of AG NPP709 in sufferers with COPD. As a result, the aim of the study was To judge the efficacy of AG NPP709 in individuals with chronic bronchitis type COPD. Berberine suppresses inflammatory